Welcome to our dedicated page for Omega Flex SEC filings (Ticker: OFLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Omega Flex's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Omega Flex's regulatory disclosures and financial reporting.
Omega Flex, Inc. reported that Chief Executive Officer and director Dean W. Rivest acquired a grant of 2,461 units of phantom stock on February 18, 2026. The award was recorded at a price of $0.00 per unit, indicating it was a compensation grant rather than an open-market purchase.
Each unit of phantom stock is the economic equivalent of one share of Omega Flex common stock, giving the CEO value tied to the company’s share performance without issuing actual shares at this time.
Omega Flex Inc received an amended Schedule 13G/A showing updated institutional ownership of its ordinary shares. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 659,683 shares, representing 6.5% of the class, with a mix of sole and shared voting and dispositive power. Virtus Investment Advisers, LLC reports 395,506 shares, or 3.9%, and Virtus Equity Trust on behalf of Virtus KAR Small-Cap Growth Fund reports 377,572 shares, or 3.7%; these amounts are also included in the totals of their respective affiliated reporting persons. The securities are certified as acquired and held in the ordinary course of business, without the purpose or effect of changing or influencing control of Omega Flex.
Omega Flex, Inc. insider reporting as both a director and 10% owner reported a common stock transaction dated 12/10/2025. The Form 4 shows a transaction in common stock with transaction code G, where 4,000 shares were disposed of at a price of $0. Following this transaction, the reporting person is shown as beneficially owning 496,394 shares of common stock indirectly "By Trust" in that line.
The report also lists additional beneficial holdings of Omega Flex common stock across several direct and indirect accounts, including 2,673,899 shares indirectly "By John E. Reed Trust (1)" and 769,887 shares held directly, along with several other trust positions. A footnote states that filing this statement should not be construed as an admission that the person is the beneficial owner of the equity securities covered for Section 16 purposes.
Omega Flex, Inc. director reported open-market purchases of the company’s common stock dated 12/10/2025. The director bought 242 shares at $30.62 per share and 142 shares at $30.67 per share in transactions coded as purchases. Following these trades, the director beneficially owns 1,384 shares directly and 826 shares indirectly through a corporation. The report states that beneficial ownership of the indirectly held shares is disclaimed except to the extent of the director’s pecuniary interest.
Omega Flex, Inc. (OFLX) director and president reported an open-market purchase of company stock. On 11/24/2025, the insider bought 500 shares of common stock at a price of $27.29 per share, classified as an acquisition. Following this transaction, the insider directly owned 1,000 common shares.
The filing also notes an additional 394 equivalent shares held indirectly through the issuer’s 401(k) plan, based on the plan statement as of 9/30/2025. The report is a standard Form 4 disclosure of insider trading activity and ownership.
Omega Flex, Inc. (OFLX) reported Q3 2025 results showing softer demand and higher costs. Net sales were $24.234 million versus $24.880 million a year ago, while gross margin eased to 60.2% from 61.7% as staffing-related costs and tariffs weighed on profitability. Operating profit fell to $4.185 million from $5.468 million, and EPS was $0.37 versus $0.46.
For the first nine months of 2025, sales were $73.089 million compared to $74.716 million, with operating profit of $12.957 million versus $15.809 million and EPS of $1.13 versus $1.32. The company ended the quarter with $49.368 million in cash, no debt, and an undrawn $15 million credit facility. Quarterly dividends of $0.34 per share continued, with $10.297 million declared year-to-date.
Management cited lower unit volumes, particularly tied to a challenged residential housing market, and higher engineering and administrative expenses. Product liability reserves within insurance retentions declined to $322,000, and the aggregate maximum exposure for open claims within retentions was estimated at approximately $4.207 million.
Omega Flex, Inc. (OFLX) furnished an earnings press release reporting results for the three and nine months ended September 30, 2025. The company disclosed this via an 8-K under Item 2.02, and attached the press release as Exhibit 99.1.
The information is furnished, not filed, under the Exchange Act. The filing also includes Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.
Omega Flex (NASDAQ: OFLX) filed its Q2-25 Form 10-Q. Net sales grew 3.7 % to $25.5 m, but a 140 bp slip in gross margin (60.4 %) and higher selling, G&A and engineering spend cut operating profit 10.6 % to $4.7 m. Net income attributable to OFLX declined 7.6 % to $4.2 m, and EPS fell to $0.41 from $0.45.
First-half trends were softer. Six-month sales eased 2 % to $48.9 m; operating profit dropped 15.2 % to $8.8 m and EPS slid 10 c to $0.77. Engineering expense rose 29 % YoY as the company invested in product development.
Balance sheet remains solid. Cash and equivalents total $50.7 m (-$1.0 m YTD) with no debt and a $15 m unused revolver. Working-capital metrics are stable; inventory at $14.5 m and A/R allowances improved. Operating cash flow was $7.0 m, essentially flat YoY, funding $1.0 m of capex and $6.9 m in dividends ($0.68 per share YTD, $0.34 declared for Q2).
Guidance & risks. Management cites weaker housing starts and higher engineering spend as headwinds. Litigation reserves fell to $0.5 m, but product-liability exposure remains; aggregate potential within insurance retentions is estimated at $5.0 m.